PharmaResearch Co., Ltd. (KOSDAQ:214450)
South Korea · Delayed Price · Currency is KRW 343,500
+7,000 (2.08%)
At close: Feb 11, 2026
PharmaResearch Market Cap
PharmaResearch has a market cap or net worth of 3.57 trillion as of February 11, 2026. Its market cap has increased by 37.13% in one year.
Market Cap
3.57T
Enterprise Value
3.27T
Revenue
496.03B
Ranking
n/a
PE Ratio
23.65
Stock Price
343,500.00
Market Cap Chart
Since July 24, 2015, PharmaResearch's market cap has increased from 1.01T to 3.57T, an increase of 253.61%. That is a compound annual growth rate of 12.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 3.57T | -14.76% |
| Dec 30, 2025 | 4.19T | 53.52% |
| Dec 30, 2024 | 2.73T | 144.17% |
| Dec 28, 2023 | 1.12T | 60.18% |
| Dec 29, 2022 | 697.32B | -14.76% |
| Dec 30, 2021 | 818.02B | 48.15% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SK Biopharmaceuticals | 8.59T |
| HLB Co., Ltd. | 7.00T |
| LigaChem Biosciences | 6.50T |
| Peptron | 5.96T |
| SK bioscience | 3.95T |
| Voronoi | 3.93T |
| D&D Pharmatech | 3.57T |
| Hugel | 2.81T |